Celltrion is trading at 194400.00 as of the 25th of December 2024, a 0.26 percent increase since the beginning of the trading day. The stock's open price was 193900.0. Celltrion has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days.Celltrion has reported 1 for 1 split on 27th of December 2024. The performance scores are derived for the period starting the 25th of November 2024 and ending today, the 25th of December 2024. Click here to learn more.
Celltrion, Inc. researches, develops, manufactures, and sells biopharmaceutical solutions in South Korea and internationally. More on Celltrion
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Celltrion's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Celltrion or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Celltrion (068270) is traded on KOSDAQ in Korea and employs 890 people. The company currently falls under 'Mega-Cap' category with a current market capitalization of 11.19 T. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Celltrion's market, we take the total number of its shares issued and multiply it by Celltrion's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Celltrion operates under Healthcare sector and is part of Pharmaceuticals And Biosciences industry.
Celltrion has accumulated about 125.54 B in cash with 113.85 B of positive cash flow from operations.
Check Celltrion Probability Of Bankruptcy
Celltrion Risk Profiles
Although Celltrion's alpha and beta are two of the key measurements used to evaluate Celltrion's performance over the market, the standard measures of volatility play an important role as well.
Our tools can tell you how much better you can do entering a position in Celltrion without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.
Did you try this?
Run Premium Stories Now
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Celltrion financial ratios help investors to determine whether Celltrion Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Celltrion with respect to the benefits of owning Celltrion security.